• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[恶性纤维组织细胞瘤。组织学检查结果的预后价值]

[Malignant fibrous histiocytoma. Prognostic value of the histological findings].

作者信息

Donhuijsen K, Kroll M, Krause U

出版信息

Dtsch Med Wochenschr. 1986 Jan 10;111(2):46-51. doi: 10.1055/s-2008-1068399.

DOI:10.1055/s-2008-1068399
PMID:3000721
Abstract

Surgical specimens after excision of malignant fibrous histiocytomas from 41 patients were classified histologically according to subtype; semiquantitatively by cell content, mitosis count, necrosis tendency and cell polymorphism; and "subjective grading". There was no significant difference in survival time between storiform-pleomorphic and myxoid subtypes. The marked scatter in the storiform-pleomorphic subtype reflects the inhomogeneity of this group. Analysis of the individual semiquantitative criteria gave better results. Cases with many mitoses, many necroses, marked cell polymorphism and high cell content had significantly shorter survival times than those with less marked changes. "Subjective grading" was also of prognostic value. However, overlapping of prognostic factors and limitations due to tumour biology allow of only a rough orientating prediction based on histological assessment of malignancy grade.

摘要

对41例恶性纤维组织细胞瘤切除术后的手术标本进行组织学亚型分类;根据细胞含量、有丝分裂计数、坏死倾向和细胞多形性进行半定量分析;并进行“主观分级”。席纹状多形性亚型和黏液样亚型之间的生存时间无显著差异。席纹状多形性亚型中明显的离散性反映了该组的不均一性。对各个半定量标准的分析得出了更好的结果。有许多有丝分裂、许多坏死、明显细胞多形性和高细胞含量的病例,其生存时间明显短于变化不明显的病例。“主观分级”也具有预后价值。然而,由于肿瘤生物学特性导致的预后因素重叠和局限性,仅能基于恶性程度的组织学评估进行粗略的定向预测。

相似文献

1
[Malignant fibrous histiocytoma. Prognostic value of the histological findings].[恶性纤维组织细胞瘤。组织学检查结果的预后价值]
Dtsch Med Wochenschr. 1986 Jan 10;111(2):46-51. doi: 10.1055/s-2008-1068399.
2
Malignant fibrous histiocytoma of the extremity.肢体恶性纤维组织细胞瘤
Cancer. 1999 Apr 15;85(8):1765-72.
3
Results of surgery for malignant fibrous histiocytomas of soft tissue.软组织恶性纤维组织细胞瘤的手术结果。
Int J Clin Oncol. 2003 Apr;8(2):104-9. doi: 10.1007/s101470300018.
4
The rise and fall of malignant fibrous histiocytoma.恶性纤维组织细胞瘤的兴衰
Ultrastruct Pathol. 2004 Sep-Dec;28(5-6):283-9. doi: 10.1080/019131290882150.
5
Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report.软组织恶性纤维组织细胞瘤的预后因素分析及化疗:初步报告
Jpn J Clin Oncol. 1994 Jun;24(3):154-9.
6
Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.深部“良性”纤维组织细胞瘤:69例罕见肿瘤的临床病理分析,提示偶有转移潜能
Am J Surg Pathol. 2008 Mar;32(3):354-62. doi: 10.1097/PAS.0b013e31813c6b85.
7
[Malignant fibrous histiocytoma of the soft tissues].[软组织恶性纤维组织细胞瘤]
Arkh Patol. 1985;47(9):20-8.
8
Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.恶性纤维组织细胞瘤的比较基因组杂交揭示了一种新的预后标志物。
Am J Pathol. 1997 Oct;151(4):1153-61.
9
[Prognosis in patients with malignant fibrous histiocytoma of the soft tissues].[软组织恶性纤维组织细胞瘤患者的预后]
Vopr Onkol. 1988;34(7):803-8.
10
Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.增殖活性(MIB-1指数)是除恶性纤维组织细胞瘤外其他亚型的高级别软组织肉瘤患者的独立预后参数:一项纳入216例软组织肉瘤的回顾性免疫组织学研究。
Histopathology. 1998 Jun;32(6):536-46.